Donations
For patients
For patients
Overview
For Patients
Take part in the trials
Genetic counseling
Researchers
Researchers
Overview
Trials
Young Oncology Academy
Awards & Fellowships
Publications
Services
Electronic Data Capture
Your support
Your support
Overview
Patronage
Credit card
Inheritances and legacies
Foundations and institutions
Pharmaceutical partnerships & sponsoring
Latest news
Latest news
Overview
News
Events
About us
About us
Overview
About Swiss Cancer Institute
Career
Members & Network
EN
DE
FR
EN
English (United States)
German (Switzerland)
French (France)
Donations
Studie zeigt: Immuntherapie verdoppelt Überlebenschance bei operablem Lungenkrebs
Studie zeigt: Immuntherapie verdoppelt Überlebenschance bei operablem Lungenkrebs
Press Release
20251002 Onkologie Studie Lungenkrebs
